News

Deal Announcements

Arete Therapeutics Closes Series A Financing

Thursday, November 20, 2008 5:57:00 AM PDT | VentureDeal Staff
Hayward, California  --  Pharmaceutical company Arete Therapeutics said that it has raised the final $16.7 million tranche of its series A financing round.

Arete is developing small molecule drugs directed at targets for cardiovascular diseases and inflammation.

Investors in the round included Frazier Healthcare Ventures, Alta Partners, Burrill & Co., Three Arch Partners and Altitude Capital Partners. The company did not disclose how it would use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1